These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 26126959)

  • 21. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can compression induce demixing in amorphous solid dispersions? A case study of naproxen-PVP K25.
    Ayenew Z; Paudel A; Van den Mooter G
    Eur J Pharm Biopharm; 2012 May; 81(1):207-13. PubMed ID: 22293573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of excipients on dissolution enhancement of aceclofenac solid dispersions studied using response surface methodology: a technical note.
    Kumar S; Gupta SK
    Arch Pharm Res; 2014 Mar; 37(3):340-51. PubMed ID: 23674128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of ternary solid dispersions of itraconazole, PEG 6000, and HPMC 2910 E5.
    Janssens S; de Armas HN; Roberts CJ; Van den Mooter G
    J Pharm Sci; 2008 Jun; 97(6):2110-20. PubMed ID: 17847067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimizing the ability of PVP/PEG mixtures to be used as appropriate carriers for the preparation of drug solid dispersions by melt mixing technique using artificial neural networks: I.
    Papadimitriou SA; Barmpalexis P; Karavas E; Bikiaris DN
    Eur J Pharm Biopharm; 2012 Sep; 82(1):175-86. PubMed ID: 22732266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.
    Karavas E; Georgarakis E; Sigalas MP; Avgoustakis K; Bikiaris D
    Eur J Pharm Biopharm; 2007 Jun; 66(3):334-47. PubMed ID: 17267194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of drug-polymer interactions on the aqueous solubility of milled solid dispersions.
    Al-Obaidi H; Lawrence MJ; Shah S; Moghul H; Al-Saden N; Bari F
    Int J Pharm; 2013 Mar; 446(1-2):100-5. PubMed ID: 23410988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and characterisation of Kolliphor® P 188 and P 237 solid dispersion oral tablets containing the poorly water soluble drug disulfiram.
    Ramadhani N; Shabir M; McConville C
    Int J Pharm; 2014 Nov; 475(1-2):514-22. PubMed ID: 25218186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relating hydrogen-bonding interactions with the phase behavior of naproxen/PVP K 25 solid dispersions: evaluation of solution-cast and quench-cooled films.
    Paudel A; Nies E; Van den Mooter G
    Mol Pharm; 2012 Nov; 9(11):3301-17. PubMed ID: 23009610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique.
    Shinde VR; Shelake MR; Shetty SS; Chavan-Patil AB; Pore YV; Late SG
    J Pharm Pharmacol; 2008 Sep; 60(9):1121-9. PubMed ID: 18718114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solid dispersion of quercetin in cellulose derivative matrices influences both solubility and stability.
    Li B; Konecke S; Harich K; Wegiel L; Taylor LS; Edgar KJ
    Carbohydr Polym; 2013 Feb; 92(2):2033-40. PubMed ID: 23399255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining SEM, TEM, and micro-Raman techniques to differentiate between the amorphous molecular level dispersions and nanodispersions of a poorly water-soluble drug within a polymer matrix.
    Karavas E; Georgarakis M; Docoslis A; Bikiaris D
    Int J Pharm; 2007 Aug; 340(1-2):76-83. PubMed ID: 17478064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability and solubility enhancement of ellagic acid in cellulose ester solid dispersions.
    Li B; Harich K; Wegiel L; Taylor LS; Edgar KJ
    Carbohydr Polym; 2013 Feb; 92(2):1443-50. PubMed ID: 23399175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of the interactions of enteric and hydrophilic polymers to enhance dissolution of griseofulvin following hot melt extrusion processing.
    Bennett RC; Keen JM; Bi YV; Porter S; Dürig T; McGinity JW
    J Pharm Pharmacol; 2015 Jul; 67(7):918-38. PubMed ID: 25645386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier.
    Khan AW; Kotta S; Ansari SH; Sharma RK; Ali J
    Drug Dev Ind Pharm; 2015 May; 41(5):772-9. PubMed ID: 24669978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insight into extravasation and internalization of nanoparticles.
    Park K
    J Control Release; 2015 May; 206():243. PubMed ID: 25907318
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and in-vivo assessment of the bioavailability of oridonin solid dispersions by the gas anti-solvent technique.
    Li S; Liu Y; Liu T; Zhao L; Zhao J; Feng N
    Int J Pharm; 2011 Jun; 411(1-2):172-7. PubMed ID: 21511016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyvinylpyrrolidone oral films of enrofloxacin: film characterization and drug release.
    Kumar GP; Phani AR; Prasad RG; Sanganal JS; Manali N; Gupta R; Rashmi N; Prabhakara GS; Salins CP; Sandeep K; Raju DB
    Int J Pharm; 2014 Aug; 471(1-2):146-52. PubMed ID: 24858388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.